Journal
MABS
Volume 8, Issue 3, Pages 574-584Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/19420862.2016.1148850
Keywords
dengue virus; monoclonal antibody; fusion; bispecific antibody; neutralizing activity; Attachment
Categories
Funding
- National Key Project for Infectious Diseases [2012ZX10002012-009]
- National Natural Science Foundation of China [81101243, 31270974, 31500755]
- Shanghai Key Laboratory of Cell Engineering [14DZ2272300]
- Shanghai Leading Academic Discipline Project [B905]
- Military Logistic Project [CWS12J086]
- Excellent Young Scientist Program of NSFC [81522025]
Ask authors/readers for more resources
Although dengue virus (DENV) infection severely threatens the health of humans, no specific antiviral drugs are currently approved for clinical use against DENV infection. Attachment and fusion are 2 critical steps for the flavivirus infection, and the corresponding functional epitopes are located at E protein domain III (E-DIII) and domain II (E-DII), respectively. Here, we constructed a bispecific antibody (DVD-1A1D-2A10) based on the 2 well-characterized anti-DENV monoclonal antibodies 1A1D-2 (1A1D) and 2A10G6 (2A10). The 1A1D antibody binds E-DIII and can block the virus attaching to the cell surface, while the 2A10 antibody binds E-DII and is able to prevent the virus from fusing with the endosomal membrane. Our data showed that DVD-1A1D-2A10 retained the antigen-binding activity of both parental antibodies. Importantly, it was demonstrated to be significantly more effective at neutralizing DENV than its parental antibodies both in vitro and in vivo, even better than the combination of them. To eliminate the potential antibody-dependent enhancement (ADE) effect, this bispecific antibody was successfully engineered to prevent Fc-gamma-R interaction. Overall, we generated a bispecific anti-DENV antibody targeting both attachment and fusion stages, and this bispecific antibody broadly neutralized all 4 serotypes of DENV without risk of ADE, suggesting that it has great potential as a novel antiviral strategy against DENV.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available